semaglutide vs tirzepatide compound Standard Dose Microdose GLP-1: & – PlexusDx Tirzepatide vs Semaglutide Compared |

Establish a consistent daily routine for meals and bathroom visits to support regular bowel patterns

Insulin resistance or type 2 diabetes: patients with type 2 diabetes typically lose less weight on Mounjaro than those without (SURMOUNT-2: mean 15.7% vs 22.5%)

Gastrointestinal symptoms represent a likely indirect cause of sleep disruption

Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces significant weight loss by regulating hunger and metabolism, but some patients report increased hair shedding within weeks of starting treatment

Mounjaro, Wegovy, and Saxenda are all prescription-only and require a medical assessment by a qualified prescriber

September 17, 2025